Repositorio Dspace

Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)

Mostrar el registro sencillo del ítem

dc.contributor.author Manzanedo, Israel
dc.contributor.author Pereira, Fernando
dc.contributor.author Cascales-Campos, Pedro-Antonio
dc.contributor.author Muñoz-Casares, Cristóbal
dc.contributor.author Asensio, Enrique
dc.contributor.author Torres-Melero, Juan
dc.contributor.author Prada-Villaverde, Arancha
dc.contributor.author Caravaca-García, Iban
dc.contributor.author Gutiérrez-Calvo, Alberto
dc.contributor.author Vaque, Javier
dc.contributor.author Ortega, Gloria
dc.contributor.author Titos-García, Alberto
dc.contributor.author González-Sánchez, Laura
dc.contributor.author Pérez-Viejo, Estibalitz
dc.contributor.author Serrano, Ángel
dc.contributor.author Martínez-Torres, Beatriz
dc.date.accessioned 2025-11-18T12:50:07Z
dc.date.available 2025-11-18T12:50:07Z
dc.date.issued 2023-05
dc.identifier.citation Manzanedo I, Pereira F, Cascales-Campos P, Muñoz-Casares C, Asensio E, Torres-Melero J, et al. Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP). JCM. 31 de mayo de 2023;12(11):3774.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/20962
dc.description.abstract INTRODUCTION: Treatment of Peritoneal Surface Malignancies (PSM) with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has achieved results never seen before in these patients, which classically have a poor prognosis. The possibility of conducting clinical trials in these diseases is complicated, since some of them are rare, so the analysis of large databases provides very valuable scientific information. The aim of this study is to analyze the global results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP), whose objective is to register all patients scheduled for HIPEC nationwide. METHODS: This is a retrospective analysis of the data recorded in the REGECOP from 36 Spanish hospitals from 2001 to 2021. There were 4159 surgical interventions in 3980 patients. RESULTS: 66% are women and 34% are men with a median age of 59 years (range 17-86). 41.5% of the patients were treated for Peritoneal Metastases (PM) of colorectal cancer (CRC); 32.4% were women with ovarian cancer (OC) with PM; 12.8% were treated for pseudomyxoma peritonei (PMP); 6.2% had PM from gastric cancer (GC); 4.9% had PM of non-conventional origin; and, finally, 2.1% of cases were patients diagnosed with peritoneal mesothelioma. The median Peritoneal Cancer Index (PCI) was 9 (0-39), and complete cytoreduction was achieved in 81.7% of the procedures. Severe morbidity (Dindo-Clavien grade III-IV) was observed in 17.7% of surgeries, with 2.1% mortality. Median hospital stay was 11 days (0-259). Median overall survival (OS) was 41 months for CRC patients, 55 months for women with OC, was not reached in PMP patients, was 14 months for GC patients, and 66 months in mesothelioma patients. CONCLUSIONS: large databases provide extremely useful data. CRS with HIPEC in referral centers is a safe treatment with encouraging oncologic results in PSM.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución-NoComercial-SinDerivadas 3.0 España
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/ *
dc.title Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 37297969
dc.relation.publisherversion https://www.mdpi.com/2077-0383/12/11/3774
dc.identifier.doi 10.3390/jcm12113774
dc.journal.title Journal of Clinical Medicine
dc.identifier.essn 2077-0383


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta